JP2000516965A5 - - Google Patents

Download PDF

Info

Publication number
JP2000516965A5
JP2000516965A5 JP1999501622A JP50162299A JP2000516965A5 JP 2000516965 A5 JP2000516965 A5 JP 2000516965A5 JP 1999501622 A JP1999501622 A JP 1999501622A JP 50162299 A JP50162299 A JP 50162299A JP 2000516965 A5 JP2000516965 A5 JP 2000516965A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP1999501622A
Other languages
English (en)
Japanese (ja)
Other versions
JP4380802B2 (ja
JP2000516965A (ja
Filing date
Publication date
Priority claimed from GB9712434A external-priority patent/GB2326334A/en
Application filed filed Critical
Publication of JP2000516965A publication Critical patent/JP2000516965A/ja
Publication of JP2000516965A5 publication Critical patent/JP2000516965A5/ja
Application granted granted Critical
Publication of JP4380802B2 publication Critical patent/JP4380802B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP50162299A 1997-06-13 1998-06-10 医薬用エアロゾル組成物 Expired - Lifetime JP4380802B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB9712434.1 1997-06-13
GB9712434A GB2326334A (en) 1997-06-13 1997-06-13 Pharmaceutical aerosol compositions
PCT/EP1998/003533 WO1998056349A1 (en) 1997-06-13 1998-06-10 Pharmaceutical aerosol composition

Publications (3)

Publication Number Publication Date
JP2000516965A JP2000516965A (ja) 2000-12-19
JP2000516965A5 true JP2000516965A5 (2) 2005-12-08
JP4380802B2 JP4380802B2 (ja) 2009-12-09

Family

ID=10814179

Family Applications (1)

Application Number Title Priority Date Filing Date
JP50162299A Expired - Lifetime JP4380802B2 (ja) 1997-06-13 1998-06-10 医薬用エアロゾル組成物

Country Status (44)

Country Link
EP (2) EP0920302B2 (2)
JP (1) JP4380802B2 (2)
KR (1) KR100546239B1 (2)
CN (1) CN1138532C (2)
AR (1) AR012977A1 (2)
AT (1) ATE222751T1 (2)
AU (1) AU729966B2 (2)
BG (1) BG63906B1 (2)
BR (1) BR9805993B1 (2)
CA (1) CA2263445C (2)
CO (1) CO4940408A1 (2)
CZ (1) CZ295521B6 (2)
DE (1) DE69807420T3 (2)
DK (1) DK0920302T4 (2)
DZ (1) DZ2516A1 (2)
EA (1) EA001259B1 (2)
EE (1) EE03664B1 (2)
ES (1) ES2182351T5 (2)
GB (1) GB2326334A (2)
GE (1) GEP20012462B (2)
HR (1) HRP980317B1 (2)
HU (1) HU228487B1 (2)
ID (1) ID21491A (2)
IL (1) IL128484A (2)
IN (1) IN189317B (2)
IS (1) IS2435B (2)
IT (1) IT1293803B1 (2)
MA (1) MA26507A1 (2)
ME (2) MEP44008A (2)
MY (1) MY119074A (2)
NO (1) NO327775B1 (2)
NZ (1) NZ334149A (2)
PL (1) PL193721B1 (2)
PT (1) PT920302E (2)
RS (1) RS51274B (2)
SA (1) SA98190821B1 (2)
SI (1) SI0920302T2 (2)
SK (1) SK284430B8 (2)
TN (1) TNSN98087A1 (2)
TR (1) TR199900288T1 (2)
TW (1) TW555570B (2)
UA (1) UA70289C2 (2)
WO (1) WO1998056349A1 (2)
ZA (1) ZA985136B (2)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9616237D0 (en) 1996-08-01 1996-09-11 Norton Healthcare Ltd Aerosol formulations
US20010031244A1 (en) 1997-06-13 2001-10-18 Chiesi Farmaceutici S.P.A. Pharmaceutical aerosol composition
IT1303788B1 (it) * 1998-11-25 2001-02-23 Chiesi Farma Spa Formulazioni di aerosol medicinali.
DZ2947A1 (fr) * 1998-11-25 2004-03-15 Chiesi Farma Spa Inhalateur à compteur de dose sous pression.
IT1313553B1 (it) 1999-07-23 2002-09-09 Chiesi Farma Spa Formulazioni ottimizzate costituite da soluzioni di steroidi dasomministrare per inalazione.
AU7026800A (en) 1999-09-11 2001-04-17 Glaxo Group Limited Pharmaceutical formulation of fluticasone propionate
DE60017450T2 (de) * 1999-11-23 2006-03-02 Glaxo Group Ltd., Greenford Pharmazeutische formulierungen enthaltend salmeterol
ES2238334T3 (es) * 1999-12-24 2005-09-01 Glaxo Group Limited Formulacion farmaceutica en aerosol de salmeterol y propionato de fluticasona.
IT1317846B1 (it) * 2000-02-22 2003-07-15 Chiesi Farma Spa Formulazioni contenenti un farmaco anticolinergico per il trattamentodella broncopneumopatia cronica ostruttiva.
IT1318514B1 (it) * 2000-05-12 2003-08-27 Chiesi Farma Spa Formulazioni contenenti un farmaco glucocorticosteroide per iltrattamento di patologie broncopolmonari.
JP5392880B2 (ja) * 2000-05-22 2014-01-22 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
WO2002072067A2 (en) * 2001-03-12 2002-09-19 Glaxo Group Limited Pharmaceutical aerosol formulation
ES2222294T3 (es) 2001-07-02 2005-02-01 Chiesi Farmaceutici S.P.A. Formulacion optimizada de tobramicina para administracion en forma de aerosol.
EP1340492A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Aerosol formulations for pulmonary administration of medicaments having systemic effects
EP3384931B1 (en) 2002-03-01 2019-07-24 Chiesi Farmaceutici S.p.A. Formoterol superfine formulation
EP1340503A1 (en) * 2002-03-01 2003-09-03 CHIESI FARMACEUTICI S.p.A. Solution aerosol formulation containing esters of 3, 17-dihydroxy oestratriene derivates for pulmonary delivery
DE10214263A1 (de) * 2002-03-28 2003-10-16 Boehringer Ingelheim Pharma HFA-Suspensionsformulierungen enthaltend ein Anticholinergikum
EP1369113B1 (en) * 2002-06-06 2006-11-22 CHIESI FARMACEUTICI S.p.A. Solubilisation of drugs in HFA propellant by means of emulsions
WO2004071488A1 (en) * 2003-02-04 2004-08-26 Chrysalis Technologies Incorporated Perfluorocarbon and hydrofluorocarbon formulations and methods of making and using same
EP1915985A1 (en) * 2003-03-20 2008-04-30 Boehringer Ingelheim Pharmaceuticals Inc. Formulation for a Metered Dose Inhaler Using Hydro-Fluoro-Alkanes as Propellants
WO2004084858A2 (en) * 2003-03-20 2004-10-07 Boehringer Ingelheim Pharmaceuticals, Inc. Formulation for a metered dose inhaler using hydro-fluoro-alkanes as propellants
SE0303179D0 (sv) * 2003-11-26 2003-11-26 Astrazeneca Ab Novel compounds
EP1595531A1 (en) 2004-05-13 2005-11-16 CHIESI FARMACEUTICI S.p.A. Stable pharmaceutical solution formulations for pressurized metered dose inhalers
NZ552869A (en) 2004-07-02 2010-06-25 Boehringer Ingelheim Int Aerosol suspension formulations containing TG 227 ea as a propellant, an ipratropium or tiotropium salt and a small amount of free water to stabilise the composition
DE102006017320A1 (de) 2006-04-11 2007-10-18 Boehringer Ingelheim Pharma Gmbh & Co. Kg Aerosolsuspensionsformulierungen mit TG 227 ea oder TG 134 a als Treibmittel
GB0621707D0 (en) 2006-10-31 2006-12-13 Univ London Pharmacy Formulations for delivery via pressurised metered dose inhalers
GB0712454D0 (en) 2007-06-27 2007-08-08 Generics Uk Ltd Pharmaceutical compositions
US20110105449A1 (en) * 2007-11-07 2011-05-05 Astrazeneca R&D Dry powder formulations comprising ascorbic acid derivates
KR101798691B1 (ko) * 2010-09-06 2017-11-16 키에시 파르마슈티시 엣스. 피. 에이. 계량된-투여량 흡입기 및 계량된-투여량 흡입기의 사용 방법
JP5409594B2 (ja) * 2010-12-22 2014-02-05 キエシ・フアルマチエウテイチ・ソチエタ・ペル・アチオニ 加圧式定量吸入器のための安定な製薬学的溶液製剤
EP2819669B1 (de) 2012-02-28 2021-04-21 Boehringer Ingelheim International GmbH Neue treibgashaltige tiotropium-formulierung
RU2504402C1 (ru) * 2012-11-20 2014-01-20 Шолекс Девелопмент Гмбх Ингаляционный состав в форме аэрозоля для лечения бронхиальной астмы и хронической обструктивной болезни легких
GB201402513D0 (en) 2014-02-13 2014-04-02 Cardiff Scintigraphics Ltd Pressurised metered dose inhalers and method of manufacture
US20170189329A1 (en) 2014-07-29 2017-07-06 3M Innovative Properties Company Method of preparing a pharmaceutical composition
EP3436115B1 (en) 2016-03-31 2021-07-28 Chiesi Farmaceutici S.p.A. Aerosol inhalation device
EP3515451B2 (en) * 2016-09-19 2023-10-04 Mexichem Fluor S.A. de C.V. Pharmaceutical composition
WO2025039045A1 (en) * 2023-08-23 2025-02-27 Inhaler Supplies Pty Ltd Inhalable formulation for volatile actives

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4869899A (en) † 1986-03-10 1989-09-26 Walter Burghart Pharmaceutical preparation and process for producing the same
US4863720A (en) † 1986-03-10 1989-09-05 Walter Burghart Pharmaceutical preparation and methods for its production
US4899874A (en) † 1988-04-26 1990-02-13 Rehrig-Pacific Company, Inc. Stackable low depth bottle case
GB8828477D0 (en) * 1988-12-06 1989-01-05 Riker Laboratories Inc Medical aerosol formulations
US5225183A (en) † 1988-12-06 1993-07-06 Riker Laboratories, Inc. Medicinal aerosol formulations
DE3905726A1 (de) * 1989-02-24 1990-08-30 Hoechst Ag Druckgaspackung und treibmittel fuer aerosole
JP2769925B2 (ja) † 1990-10-18 1998-06-25 ミネソタ マイニング アンド マニュファクチャリング カンパニー ベクロメタゾン１７，２１ジプロピオネートを含んで成るエアロゾル製剤
GB9024365D0 (en) * 1990-11-09 1991-01-02 Glaxo Group Ltd Medicaments
EP0504112A3 (en) * 1991-03-14 1993-04-21 Ciba-Geigy Ag Pharmaceutical aerosol formulations
HUT67445A (en) † 1991-06-10 1995-04-28 Schering Corp Aerosol formulations containing 1,1,1,2-tetrafluorethane
ZA924164B (en) * 1991-06-10 1993-02-24 Schering Corp Non-chlorofluorocarbon aerosol formulations
DE4123668A1 (de) * 1991-07-17 1993-01-21 Rovema Gmbh Verfahren und vorrichtung zur zufuehrung von folienmaterial zu einer intermittierend arbeitenden schlauchbeutelmaschine
DE4123663A1 (de) * 1991-07-17 1993-01-21 Schwabe Willmar Gmbh & Co Aerosol-zubereitung und verwendung eines treibmittels dafuer
ES2079210T3 (es) * 1991-12-12 1996-01-01 Glaxo Group Ltd Formulacion farmaceutica de aerosol.
EP0617610B1 (en) * 1991-12-18 1997-03-19 Minnesota Mining And Manufacturing Company Suspension aerosol formulations
SK280911B6 (sk) * 1992-12-09 2000-09-12 Boehringer Ingelheim Pharmaceuticals, Inc. Farmaceutický prostriedok
US5502076A (en) * 1994-03-08 1996-03-26 Hoffmann-La Roche Inc. Dispersing agents for use with hydrofluoroalkane propellants
US5508023A (en) * 1994-04-11 1996-04-16 The Center For Innovative Technology Pharmaceutically acceptable agents for solubilizing, wetting, emulsifying, or lubricating in metered dose inhaler formulations which use HFC-227 propellant
US5534242A (en) † 1994-05-02 1996-07-09 Henry; Richard A. Lidocaine-vasoconstrictor aerosol preparation
JP3911290B2 (ja) † 1994-05-13 2007-05-09 アラダイム コーポレーション エアゾールを含む麻酔用処方
US5653961A (en) † 1995-03-31 1997-08-05 Minnesota Mining And Manufacturing Company Butixocort aerosol formulations in hydrofluorocarbon propellant
US5635161A (en) † 1995-06-07 1997-06-03 Abbott Laboratories Aerosol drug formulations containing vegetable oils
GB9517998D0 (en) † 1995-09-04 1995-11-08 Bioglan Lab Ltd Compositions and device for their administration
WO1998001147A1 (en) * 1996-07-08 1998-01-15 Rhone-Poulenc Rorer Limited Medicinal cyclosporin-a aerosol solution formulation
NZ336049A (en) † 1996-12-04 2000-09-29 Bioglan Ireland R & D Ltd Aersol device for administering pharmaceutical active agents in a solution of propellant, carrier and valve means for delivering this to the exterior of the container
AU718967B2 (en) † 1997-02-05 2000-05-04 Jagotec Ag Medical aerosol formulations

Similar Documents

Publication Publication Date Title
JP2000509942A5 (2)
JP2000507042A5 (2)
JP2000509635A5 (2)
JP2000509912A5 (2)
JP2000509637A5 (2)
JP2000510751A5 (2)
JP2000509587A5 (2)
JP2000507369A5 (2)
JP2000507433A5 (2)
JP2000508866A5 (2)
JP2000510793A5 (2)
JP2000508022A5 (2)
JP2000508841A5 (2)
JP2000516965A5 (2)
JP2000508680A5 (2)
JP2000509804A5 (2)
JP2000509853A5 (2)
JP2000509755A5 (2)
JP2000510247A5 (2)
JP2000510969A5 (2)
JP2000508836A5 (2)
JP2000508102A5 (2)
JP2000509818A5 (2)
JP2000509520A5 (2)
JP2000507434A5 (2)